Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Yi X, Xu L, Hiller S, Kim HS, Maeda N.

Atherosclerosis. 2012 Jul;223(1):137-43. doi: 10.1016/j.atherosclerosis.2012.04.025. Epub 2012 May 16.

2.

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.

3.

Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice.

Yi X, Xu L, Kim K, Kim HS, Maeda N.

Atherosclerosis. 2010 Aug;211(2):424-30. doi: 10.1016/j.atherosclerosis.2010.03.009. Epub 2010 Mar 10.

4.

Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.

Rasmiena AA, Barlow CK, Stefanovic N, Huynh K, Tan R, Sharma A, Tull D, de Haan JB, Meikle PJ.

Atherosclerosis. 2015 Dec;243(2):598-608. doi: 10.1016/j.atherosclerosis.2015.10.096. Epub 2015 Oct 26.

PMID:
26545014
5.

Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.

Chew P, Yuen DY, Koh P, Stefanovic N, Febbraio MA, Kola I, Cooper ME, de Haan JB.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):823-30. doi: 10.1161/ATVBAHA.109.186619. Epub 2009 Mar 26.

7.
8.

Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes.

Burris RL, Xie CH, Thampi P, Wu X, Melnyk SB, Nagarajan S.

Atherosclerosis. 2010 Sep;212(1):107-15.

PMID:
20839391
9.

Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.

Hanssen NM, Brouwers O, Gijbels MJ, Wouters K, Wijnands E, Cleutjens JP, De Mey JG, Miyata T, Biessen EA, Stehouwer CD, Schalkwijk CG.

Cardiovasc Res. 2014 Oct 1;104(1):160-70. doi: 10.1093/cvr/cvu189. Epub 2014 Aug 18.

PMID:
25139743
10.

Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.

Bu DX, Rai V, Shen X, Rosario R, Lu Y, D'Agati V, Yan SF, Friedman RA, Nuglozeh E, Schmidt AM.

Circ Res. 2010 Apr 2;106(6):1040-51. doi: 10.1161/CIRCRESAHA.109.201103. Epub 2010 Feb 4.

11.

Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.

Nogi Y, Nagashima M, Terasaki M, Nohtomi K, Watanabe T, Hirano T.

PLoS One. 2012;7(4):e35683. doi: 10.1371/journal.pone.0035683. Epub 2012 Apr 20.

12.

Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.

Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1436-44. doi: 10.1161/ATVBAHA.112.248682. Epub 2012 Apr 26.

13.

AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.

Huang Q, Qin L, Dai S, Zhang H, Pasula S, Zhou H, Chen H, Min W.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):795-804. doi: 10.1161/ATVBAHA.113.301220. Epub 2013 Feb 14.

14.

Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.

Di Marco E, Gray SP, Chew P, Kennedy K, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.

Clin Sci (Lond). 2016 Aug 1;130(15):1363-74. doi: 10.1042/CS20160249. Epub 2016 May 17.

PMID:
27190136
15.

Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice.

Boué S, Tarasov K, Jänis M, Lebrun S, Hurme R, Schlage W, Lietz M, Vuillaume G, Ekroos K, Steffen Y, Peitsch MC, Laaksonen R, Hoeng J.

Atherosclerosis. 2012 Dec;225(2):328-34. doi: 10.1016/j.atherosclerosis.2012.09.032. Epub 2012 Oct 10.

PMID:
23102783
16.

Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice.

Babaev VR, Li L, Shah S, Fazio S, Linton MF, May JM.

Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1751-7. doi: 10.1161/ATVBAHA.110.209502. Epub 2010 Jun 17.

17.

Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.

Song G, Tian H, Qin S, Sun X, Yao S, Zong C, Luo Y, Liu J, Yu Y, Sang H, Wang X.

Atherosclerosis. 2012 Mar;221(1):55-65. doi: 10.1016/j.atherosclerosis.2011.11.043. Epub 2011 Dec 13.

PMID:
22209213
18.

NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.

Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, Wang X, Castellani LW, Reue K, Lusis AJ, Araujo JA.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):58-66. doi: 10.1161/ATVBAHA.110.210906. Epub 2010 Oct 14.

19.

A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.

Fujii A, Allen TJ, Nestel PJ.

Atherosclerosis. 2007 Jul;193(1):55-61. Epub 2006 Sep 22.

PMID:
16996521
20.

Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.

Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Pugliese G.

Diabetologia. 2015 Apr;58(4):845-53. doi: 10.1007/s00125-014-3467-6. Epub 2014 Dec 4.

PMID:
25471794

Supplemental Content

Support Center